HHS Says FDA Did Not Have Power To Appoint New Chief Counsel

By Kelly Lienhard / January 12, 2021 at 5:09 PM
A senior HHS official told Inside Health Policy that FDA Commissioner Stephen Hahn must have misspoken when he sent out an agency-wide email naming Mark Raza as the acting chief counsel for the agency, asserting that neither Hahn nor any other FDA officials have the authority to appoint someone to the chief counsel position. In his email, sent out Monday (Jan. 11), Hahn announced that Raza, who currently serves as the agency’s principal deputy chief counsel, would temporarily fill in...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.